Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Novacyt confirms end of Yourgene Taiwan disposal discussions

(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan. The AIM-traded firm noted that Yourgene Health initially announced the acquisition on 13 June 2023.

As a result of the termination, Yourgene's Taiwanese laboratory business would remain within the Novacyt group.

"The board does not consider the divestment material and will continue to evaluate a number of options in relation to the future of the Taiwanese laboratory business that offer the best value to all stakeholders," the Novacyt board said in its statement.

At 1158 GMT, shares in Novacyt were down 5.77% at 47.35p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Bluejay to broaden into helium and industrial gases
(Sharecast News) - Bluejay Mining announced a strategic decision to broaden its corporate scope, expanding into the exploration and development of helium, industrial gases, and hydrocarbons, on Friday.
Man Group's Q1 miss was temporary "roadbump", says Jefferies
(Sharecast News) - Shares in Man Group dropped on Friday after the investment management firm reported unexpected net outflows in the first quarter, but that didn't deter Jefferies from reiterating its 'buy' rating for the stock.
Vector Capital reports robust year-end financial position
(Sharecast News) - Commercial lender Vector Capital reported continued growth in shareholders' equity while maintaining dividends and implementing prudent bad debt provision policies in its full-year results on Friday.
Quadrise posts progress with Utah partner Valkor
(Sharecast News) - Quadrise updated the market on its collaboration with Valkor Technologies in Utah on Friday, targeting the supply of low sulphur 'MSAR' and 'bioMSAR' to the marine and power sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.